United States · FDA National Drug Code directory
OLANZAPINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83854-003_4c557545-1a58-5183-e063-6394a90a1028
- Product NDC
- 83854-003
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- OLANZAPINE
- Labeler
- Anthea Pharma Private Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260305
- Source listing expiry
- 20271231
Source-listed ingredients
- OLANZAPINE — 10 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (83854-003-01) / 2 mL in 1 VIAL · 83854-003-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →